首页 > 市场调查报告书 > 製药

骨疾病

欧洲骨关节炎治疗市场预测至 2030 年 - 区域分析 - 按治疗类型、疾病适应症和最终用户

市场调查报告书

商品编码

1562205

欧洲骨关节炎治疗市场预测至 2030 年 - 区域分析 - 按治疗类型、疾病适应症和最终用户

Europe Osteoarthritis Therapy Market Forecast to 2030 - Regional Analysis - by Therapy Type, Disease Indication, and End User

出版日期: 2024年07月04日 | 出版商:

The Insight Partners | 英文 108 Pages | 订单完成后即时交付

价格

简介目录图表

2022年欧洲骨关节炎治疗市值为49.7151亿美元，预计2030年将达到87.4393亿美元；预计2022年至2030年复合年增长率为7.3%。

再生医学的可用性推动欧洲骨关节炎治疗市场

再生医学是治疗 OA 的传统疗法的一种新的、具有潜在变革性的替代方案。再生医学利用生物医学工程、生物材料和针对人体免疫系统的细胞疗法来治疗骨关节炎。此外，临床研究人员也开发了使用患者（自体）细胞修復患者关节软骨的方法。此外，再生疗法选择使用「基质诱导自体软骨细胞植入（MACI）」。 MACI 可以修復小面积的软骨，最后预防或延后 OA。此外，一些製造商正在开发专注于再生疗法的产品。对 PRP 疗法、干细胞疗法、透明质酸注射和增殖疗法等非手术方法的日益青睐将推动再生医学的采用。患有 OA 的患者可以使用非药物疗法进行治疗。再生疗法可以透过最终减轻骨关节炎患者的疼痛并提高整体生活品质来改善关节功能。因此，再生医学的日益普及预计将在预测期内为骨关节炎治疗市场带来新的商机。

欧洲骨关节炎治疗市场概况

欧洲骨关节炎治疗市场分为德国、英国、法国、义大利、西班牙和欧洲其他地区。该地区骨关节炎治疗药物的快速产品批准和先进的医疗基础设施是市场成长的最有影响力的因素。根据《健康监测杂誌》报道，骨关节炎是德国最常见的关节疾病。关节疼痛和功能丧失可能会导致生活品质下降，因为骨关节炎是由上肢（手指、手和肩膀）引起的。因此，随着德国人口老化，骨关节炎盛行率将持续上升，对医疗保健系统造成沉重负担。根据世界卫生组织（WHO）2020年发布的报告，德国骨关节炎死亡人数占总死亡人数的0.05%。此外，新产品的推出促进了市场成长。例如，2023年5月，格伦泰宣布其研究性非阿片类药物「树脂毒素（RTX）」获得批准，该药物目前正在进行临床3期开发，并被美国食品和药物管理局（USFDA）视为治疗膝骨关节炎的突破性疗法。树脂毒素可以是一种有意义的非鸦片类药物治疗选择，提供持久的疼痛缓解和受影响关节的功能改善。

欧洲骨关节炎治疗市场收入及 2030 年预测（百万美元）

欧洲骨关节炎治疗市场区隔

欧洲骨关节炎治疗市场按治疗类型、疾病适应症、最终用户和国家分类。

依治疗类型，欧洲骨关节炎治疗市场分为经皮神经电刺激（TENS）、职能治疗、物理治疗、富血小板血浆（PRP）治疗及基质血管成分、增生疗法等。 2022 年，物理治疗领域占据最大的市场。

从疾病适应症来看，欧洲骨关节炎治疗市场细分为膝骨关节炎、脊椎骨关节炎、足踝骨关节炎、肩骨关节炎、手骨关节炎等。到 2022 年，膝骨关节炎细分市场将占据欧洲骨关节炎治疗市场的最大份额。

根据最终用户，欧洲骨关节炎治疗市场分为医院和诊所、专科诊所、门诊手术中心、家庭护理等。 2022 年，家庭护理领域占据欧洲骨关节炎治疗市场的最大份额。

依国家/地区划分，欧洲骨关节炎治疗市场分为英国、德国、法国、义大利、西班牙和欧洲其他地区。 2022 年，德国在欧洲骨关节炎治疗市场占有率中占据主导地位。

Zimmer Biomet Holdings Inc、DePuy Synthes Inc、Bioventus Inc、Omron Healthcare Inc、Exactech Inc 和 Medi GmbH & Co KG 是欧洲骨关节炎治疗市场上的一些领先公司。

Regenerative medicine is a new and potentially transformative alternative to traditional therapy options to treat OA. Regenerative medicine utilizes biomedical engineering, biomaterials, and cell therapies that target the body's immune system to treat OA. Also, clinical researchers have developed methods to fix the articular cartilage of patients using patients' (autologous) cells. Further, regenerative therapy options use "Matrix-Induced Autologous Chondrocyte Implantation (MACI)." MACI can repair small areas of cartilage, ultimately preventing or postponing OA. Also, several manufacturers are developing products focused on regenerative therapy. Rising inclination toward non-surgical approaches such as PRP therapy, stem cell therapy, hyaluronic acid injections, and prolotherapy would propel the adoption of regenerative medicine. Patients suffering from OA can be treated using non-pharmacological therapies. Regenerative therapy options can improve joint functions by ultimately reducing pain and enhancing the overall quality of life for individuals suffering from OA. Therefore, increasing adoption of regenerative medicine is expected to open new business opportunities in the osteoarthritis therapy market during the forecast period.

Europe Osteoarthritis Therapy Market Overview

Europe osteoarthritis therapy market is segmented as Germany, the UK, France, Italy, Spain, and the Rest of Europe. Fast product approvals in the region for osteoarthritis treatment drugs and advanced healthcare infrastructure are the most influential factors responsible for market growth. According to the Journal of Health Monitoring report, osteoarthritis is the most common joint disease in Germany. Joint pain and loss of function are likely to result in loss of quality of life as osteoarthritis is caused in the upper extremities (fingers, hands, and shoulders). Therefore, with the aging of Germany's population, osteoarthritis prevalence will continue to rise, resulting in a high burden on the healthcare system. According to the World Health Organization (WHO) report published in 2020, osteoarthritis deaths in Germany account for 0.05% of total deaths. Further, new product launches enhance the market growth. For instance, in May 2023, Grunenthal announced receiving approval for investigational non-opioid medicine "Resiniferatoxin (RTX)," currently undergoing Clinical Phase 3 development standing as a breakthrough therapy by the US Food and Drug Administration (USFDA) to treat knee OA. Resiniferatoxin can become a meaningful non-opioid treatment option, providing long-lasting pain relief and functional improvement of the affected joint.

Europe Osteoarthritis Therapy Market Revenue and Forecast to 2030 (US$ Million)

Europe Osteoarthritis Therapy Market Segmentation

The Europe osteoarthritis therapy market is categorized into therapy type, disease indications, end user, and country.

Based on therapy type, the Europe osteoarthritis therapy market is segmented into transcutaneous electrical nerve stimulation (TENS), occupational therapy, physical therapy, platelet-rich plasma (PRP) therapy & stromal vascular fraction, prolotherapy, and others. The physical therapy segment held the largest market share in 2022.

In terms of disease indications, the Europe osteoarthritis therapy market is segmented into knee osteoarthritis, spine osteoarthritis, foot and ankle osteoarthritis, shoulder osteoarthritis, hand osteoarthritis, and others. The knee osteoarthritis segment held the largest share of Europe osteoarthritis therapy market in 2022.

Based on end users, the Europe osteoarthritis therapy market is categorized into hospitals and clinics, specialty clinics, ambulatory surgical center, homecare, and others. The homecare segment held the largest share of Europe osteoarthritis therapy market in 2022.

By country, the Europe osteoarthritis therapy market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe osteoarthritis therapy market share in 2022.

Zimmer Biomet Holdings Inc, DePuy Synthes Inc, Bioventus Inc, Omron Healthcare Inc, Exactech Inc, and Medi GmbH & Co KG are some of the leading companies operating in the Europe osteoarthritis therapy market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Osteoarthritis Therapy Market Landscape

4.1 Pipeline Analysis
- 4.1.1 Clinical Trial Pipeline Analysis

5. Europe Osteoarthritis Therapy Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Prevalence of Osteoarthritis
- 5.1.2 Innovative Therapy Options Reducing Dependency on Medications
5.2 Market Restraints
- 5.2.1 Product Recall
5.3 Market Opportunities
- 5.3.1 Availability of Regenerative Medicine
5.4 Future Trends
- 5.4.1 More Effective Treatment Options
5.5 Impact of Drivers and Restraints:

6. Osteoarthritis Therapy Market - Europe Market Analysis

6.1 Overview
- 6.1.1 Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030

7. Europe Osteoarthritis Therapy Market Analysis - by Therapy Type

7.1 Overview
7.2 Transcutaneous Electrical Nerve Stimulation (TENS)
- 7.2.1 Overview
- 7.2.2 Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Occupational Therapy
- 7.3.1 Overview
- 7.3.2 Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Physical Therapy
- 7.4.1 Overview
- 7.4.2 Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction
- 7.5.1 Overview
- 7.5.2 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Prolotherapy
- 7.6.1 Overview
- 7.6.2 Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Others
- 7.7.1 Overview
- 7.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Osteoarthritis Therapy Market Analysis - by Disease Indication

8.1 Overview
8.2 Knee Osteoarthritis
- 8.2.1 Overview
- 8.2.2 Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Spine Osteoarthritis
- 8.3.1 Overview
- 8.3.2 Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Foot and Ankle Osteoarthritis
- 8.4.1 Overview
- 8.4.2 Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Shoulder Osteoarthritis
- 8.5.1 Overview
- 8.5.2 Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Hand Osteoarthritis
- 8.6.1 Overview
- 8.6.2 Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Osteoarthritis Therapy Market Analysis - by End User

9.1 Overview
9.2 Hospitals and Clinics
- 9.2.1 Overview
- 9.2.2 Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Specialty Clinics
- 9.3.1 Overview
- 9.3.2 Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgical Centers
- 9.4.1 Overview
- 9.4.2 Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Homecare
- 9.5.1 Overview
- 9.5.2 Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Osteoarthritis Therapy Market - Country Analysis

10.1 Europe Market Overview
- 10.1.1 Europe: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.3 United Kingdom: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.1.4 United Kingdom: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.1.5 United Kingdom: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.1.1.2 Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.3 Germany: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.2.4 Germany: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.2.5 Germany: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.1.1.3 France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.3 France: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.3.4 France: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.3.5 France: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.1.1.4 Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.4.1 Overview
    - 10.1.1.4.2 Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.4.3 Italy: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.4.4 Italy: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.4.5 Italy: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.1.1.5 Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.5.1 Overview
    - 10.1.1.5.2 Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.5.3 Spain: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.5.4 Spain: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.5.5 Spain: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.1.1.6 Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.6.1 Overview
    - 10.1.1.6.2 Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.6.3 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.6.4 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.6.5 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by End User

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in the osteoarthritis therapy market
11.3 Organic Developments
- 11.3.1 Overview
11.1 Inorganic Developments
- 11.1.1 Overview

12. Company Profiles

12.1 Zimmer Biomet Holdings Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 DePuy Synthes Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Bioventus Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Omron Healthcare Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Exactech Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Medi GmbH & Co KG
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments

13. Appendix

13.1 About the Insight Partners

简介目录图表

List Of Tables

Table 1. Osteoarthritis Therapy Market Segmentation
Table 2. Ongoing Clinical Trial of Osteoarthritis
Table 3. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 4. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 5. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 6. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 7. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 8. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 9. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 10. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 11. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 12. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 13. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 14. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 15. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 16. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 17. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 18. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 19. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 20. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 21. Organic Developments Done by Companies
Table 22. Inorganic Developments Done by Companies

List Of Figures

Figure 1. Osteoarthritis Therapy Market Segmentation, by Country
Figure 2. Osteoarthritis Therapy Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030
Figure 5. Osteoarthritis Therapy Market Share (%) - by Therapy Type (2022 and 2030)
Figure 6. Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Osteoarthritis Therapy Market Share (%) - by Disease Indication (2022 and 2030)
Figure 13. Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Osteoarthritis Therapy Market Share (%) - by End User (2022 and 2030)
Figure 20. Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Europe: Osteoarthritis Therapy Market - Revenue by Key Countries Revenue 2022 (US$ Million)
Figure 26. Europe: Osteoarthritis Therapy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 27. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 28. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 29. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 30. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 31. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 32. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 33. Growth Strategies in the Osteoarthritis Therapy market